Effect of adrenomedullin on inflammatory responses to one-lung ventilation in lobectomy patients

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-16007847

Enrollment

Unknown

Registered

2016-01-28

Start date

2016-06-30

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

one lung ventilation

Interventions

Control group:No

Adrenomedullin group:Adrenomedullin

Eligibility

Sex/Gender

All

Age

20 Years to 60 Years

Inclusion criteria

Inclusion criteria: 60 patients aged 20 to 60, ASA I-II which undergoing the lobectomy for lung cancer

Exclusion criteria

Exclusion criteria: Excluded criteria: non lung cancer patients, patients with immune dysfunction, radiotherapy and chemotherapy, pleural effusion, lung infection, hypoproteinemia, COPD and asthma were excluded.

Design outcomes

Primary

Measure	Time frame
oxygen index;TNF;C RP;stay of inhospital;IL-1;	—

Secondary

Measure	Time frame
airway pressure;lung compliance;MIP;ICAM;IL-10;IL-6;IL-8;	—

Countries

China

Contacts

Public ContactWei Gao

gaowei20055@126.com+86 13836172191

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026